Not FDA-approved

Bones & muscles

TB-500

Evidence

No human approvals

Class

Fragment of thymosin beta-4

KEY TAKEAWAY

TB-500 is a synthetic fragment of thymosin beta-4, a protein involved in cell movement and tissue repair. It has been studied in animals and is not approved for human use.

Written by the Veylo editorial team · Updated

November 2026

At a glance

At a glance

What it is

A synthetic piece of thymosin beta-4

Studied for

Tissue repair and cell migration in animal models

Key fact

Promoted healing in animal wound and heart injury models; no approved human use

Route

Injection (research use)

Evidence strength

No human approvals

What it is

What it is

TB-500 is sold as a research compound based on the active region of thymosin beta-4, a protein found in most human cells.

How it works

How it works

Thymosin beta-4 binds actin and appears to help cells migrate to damaged areas and form new blood vessels.

Regulatory status

Regulatory status

TB-500 is not approved by the FDA and is prohibited by the World Anti-Doping Agency.

What it is used for

What it is used for

Studied in animals for wound, muscle and cardiac repair. It has no approved medical use.

Side effects and risks

Side effects and risks

Human safety data are very limited. Risks of long-term use are not known.

Citations

Citations

Primary literature for this entry is being compiled.

Veylo content is educational and not medical advice. Peptides that are not FDA-approved are not approved for the uses described.

Veylo

Clinician-guided peptide care, paired with baseline blood testing and ongoing support.

Peptides referenced on this site are compounded medications and are investigational; they have not been approved by the FDA for the uses described. Nothing here is medical advice. Prescriptions are issued only after a licensed clinician reviews your history.

© 2026 Veylo. All rights reserved.

Veylo

Veylo

Veylo